Changing Models of Tech Transfer: Resulting Risks and Corresponding Practice Tips
This luncheon presentation is brought to you by the Life Sciences Practice Group.
Innovative research collaborations have developed between industry and academic medical centers, due to reductions in federal funding for research and changes to business models at biotech, device and pharma companies. Thus, the pathways to commercialization for technologies arising out of Academic Medical Centers are changing. Transformations in this realm are affecting investor involvement, physician entrepreneurialism, campus engagement and corporate partnerships.
We will seek to raise awareness of the key issues and decision points involved in these collaboration and commercialization processes. In moving through case studies, the speakers, Marlon Rajakaruna, Partner at Dentons US LLP and Elizabeth Sillay, Counsel at Waller Lansden Dortch & Davis LLP, will discuss and review the major issues that an institution should consider in the course of negotiating these research transactions, while achieving both institutional objectives and industry goals.